All Boston Children’s Hospital articles
-
News
Infectious disease surveillance platform BEACON launches as a new open-source global resource
The Biothreats Emergence, Analysis and Communications Network (BEACON), an open-source infectious diseases monitoring tool powered by AI and human experts, has been launched.
-
News
Partnering diet and intestinal microbes to protect against GI disease
New research suggests that we could get more out of our diets by harnessing intestinal microbes to break down plant compounds collectively known as phenolic glycosides. These compounds pair sugar molecules with a host of small molecules beneficial to human health.
-
News
A surprising link between Crohn’s disease and the Epstein-Barr virus
A longitudinal study has revealed strong and surprising evidence showing that exposure to Epstein-Barr virus (EBV) can lead to a higher risk of Crohn’s disease. Researchers are now trying to find out the mechanistic actions in their associations.
-
News
Researchers identify signs tied to more severe cases of RSV
In a new study, researchers found an increase in NK cells in the airways of children with severe RSV as well as other alterations that suggest these cells may be contributing to disease severity.
-
News
Scientists get to the bottom of COVID’s worst pediatric complication
Scientists investigating multisystem inflammatory syndrome in children (MIS-C) found their immune systems had latched onto a part of the coronavirus that closely resembles a protein found in their bodies, launching an attack on their own tissues.
-
News
From ‘hit to vial’: Discovery and optimization of a promising vaccine adjuvant
Scientists identified a new and promising adjuvant, dubbed PVP-037 - in principle, this compound can be added to any vaccine to enhance its action.
-
News
Boston Children’s Hospital receives a contract of up to $9 million to improve flu vaccines
The Precision Vaccines Program (PVP) at Boston Children’s Hospital has been awarded a contract from NIAID to develop a small molecule adjuvant to enhance the effectiveness of flu vaccines.